MK-5108

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-5108, covering 2018-11-09 to 2018-11-09. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001) [Phase 1]